Related Experiment Video
Updated: Feb 3, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Rational use of intravenous polymyxin B and colistin: A review
1Universiti Sains Malaysia Health Campus, School of Medical Sciences, Kubang Kerian, Kelantan, Malaysia. zakuan@usm.my.
Abstract:
Polymyxin B and colistin (polymyxin E) were introduced in clinical practice to treat Gram-negative infections in 1950s but their parenteral use waned in 1970s due to toxicity concerns. Resurgence of polymyxins use in Malaysia began approximately in 2009 due to a lack of treatment options for MDR Gram negative superbugs such as Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. However, limited experience and a lack of widespread availability of up-to-date dosing guidelines could potentially result in incorrect use of these last resort antibiotics by managing doctors. The recent report of polymyxin resistant strains is also a cause of concern. Herein, we discuss the importance of preserving the efficacy of polymyxins in hospitals, the similarities and differences between polymyxin B and colistin, issues pertaining to current use of polymxyins and strategies to improve polymyxins' prescription. Polymyxins should only be used to treat significant infections, in optimum doses and if possible, in combination with other antibiotics.
Insights
Polymyxins, vital antibiotics for Gram-negative infections, are seeing increased use but require careful dosing. Preserving their efficacy through appropriate prescription is crucial to combat resistant superbugs.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Polymyxins (B and E/colistin) were key antibiotics for Gram-negative infections since the 1950s.
- Parenteral use declined in the 1970s due to toxicity, but resurged in Malaysia around 2009.
- This resurgence was driven by a lack of alternatives for multidrug-resistant (MDR) Gram-negative bacteria like Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
Purpose of the Study:
- To highlight the importance of preserving polymyxin efficacy in hospital settings.
- To compare and contrast polymyxin B and colistin.
- To address challenges in current polymyxin use and propose strategies for improved prescription.
Main Methods:
- Review of existing literature on polymyxin B and colistin.
- Analysis of clinical use patterns and challenges.
- Discussion of resistance trends and stewardship strategies.
Main Results:
- Limited experience and dosing guidelines may lead to suboptimal polymyxin use.
- Emerging polymyxin resistance is a significant concern.
- Polymyxins are last-resort antibiotics for severe Gram-negative infections.
Conclusions:
- Optimizing polymyxin dosing and judicious use are essential.
- Combination therapy may be beneficial in certain cases.
- Strategies to improve polymyxin prescription are needed to maintain their effectiveness against MDR pathogens.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Rationalizing Substitutions
Rational Expressions
Asymptotes in Rational Functions
Rational Emotive Behavior Therapy

